Wim J.
- Country
- Belgium
- Department
- Pneumology
Research Overview
- Efficacy and Safety of Early Depemokimab Initiation as Add-on Therapy in Patients with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
- Phase 2b/3 Randomized Double‑Blind Placebo‑Controlled Trial of Lunsekimig in Adults with Inadequately Controlled Eosinophilic COPD
- Efficacy and Safety Evaluation of Astegolimab in Chronic Obstructive Pulmonary Disease: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study
Data & Insights
Has run more than one trial at 165 of 432 partner sites.
Specializations
Respiratory Medicine
This investigator specializes in treating chronic respiratory conditions, with particular expertise in Chronic Obstructive Pulmonary Disease (COPD) and its various manifestations.
- COPD Management
- Airflow Limitation Treatment
- Respiratory Function Assessment
The focus includes evaluation of innovative therapeutic approaches for managing respiratory conditions and preventing exacerbations.
Genetic Disorders
The investigator has developed expertise in treating congenital Alpha-1 Antitrypsin Deficiency, a genetic condition affecting respiratory function.
- Genetic Respiratory Disorders
- Enzyme Replacement Therapy
- Inherited Metabolic Disorders
Their work encompasses the management of both moderate and severe manifestations of genetic respiratory conditions.
Therapeutic Innovation
The investigator explores novel therapeutic approaches for respiratory conditions, including inhalation therapies and biological treatments.
- Advanced Inhalation Treatments
- Biological Therapies
- Long-term Disease Management
Their expertise extends to evaluating new treatment modalities for chronic respiratory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.